Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individuals undergoing lung cancer screening (LCS); however, adherence rates appear to ...

Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO ...

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...

Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...

Oryzon has been invited to participate at the Van Lanschot Kempen Life Sciences Conference, which will take place in their offices located in Amsterdam (Netherlands) on April 1-3, where the company ...

Cancer-associated fibroblasts (CAFs) play an important role in metastatic melanoma, and an enhanced understanding of that role could lead to important new therapeutic pathways, according to a new ...

Agilent Technologies Inc. today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early ...

Cancer Biologics Market 2025 Biologic drug is a product that contain components of living organisms such as animal, human, or produced from ...

The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...

Detailed price information for Cero Therapeutics Holdings Inc (CERO-Q) from The Globe and Mail including charting and trades.